Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor

Abroad (travel likely)RecruitingPHASE2

Conditions

Neuroendocrine Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Contact: Study coordinator (Hong Zhao) · pumc95zhao@126.com · 010-87787100
    Contact: Study coordinator (Yihebali Chi) · 010-87787100
Study leads
  • Hong Zhao

    Study Director

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences